Articles from Science Exchange

Science Exchange, a leading provider of life sciences procurement and supplier management SaaS solutions, today announced the acquisition of HappiLabs, a Chicago-based software and services company specializing in scientific procurement support. This strategic acquisition strengthens Science Exchange’s ability to serve biotech and pharmaceutical companies by deepening procurement expertise and expanding access to high-quality purchasing insights.

Science Exchange, the leading SaaS provider of supplier orchestration solutions for the life sciences industry, today announced the launch of its Clinical Development Solution. Designed to address the unique challenges faced by clinical operations and procurement teams managing outsourced clinical studies, the platform provides pharmaceutical sponsors with the tools to efficiently orchestrate the entire contracting and collaboration process across suppliers—whether in functional service provider (FSP) or full-service outsourcing (FSO) models.

Science Exchange, a leading provider of life sciences procurement and supplier management SaaS solutions, today announced its acquisition by Waud Capital Partners (“Waud Capital”), a growth-oriented middle-market private equity firm specializing in the software & technology and healthcare sectors. This acquisition marks a significant milestone in Science Exchange’s journey and will compound the company’s impressive performance, growth trajectory, and software capabilities. The partnership with Waud Capital will enable the company to accelerate its mission to transform the purchasing and supplier orchestration landscape for life sciences organizations.

Science Exchange, a leader in life sciences purchasing and supplier management, announces the release of its first-ever supplier orchestration platform. Designed specifically for life sciences companies, this innovative solution aims to harmonize the complex procurement and supplier management process, enabling faster supplier collaboration and lower R&D costs.

Science Exchange, the first purchasing and supplier orchestration platform for life sciences, is thrilled to announce the appointment of former Moderna Executive Ander Tallett as its Chief Strategy Officer (CSO).